Amy Wagers, a researcher at the Harvard Stem Cell Institute and Joslin Diabetes Center in Boston, has retracted a high-profile paper published earlier this year in the journal Nature. According to my Technology Review story on the study,
Researchers surgically connected the circulatory systems of two mice, allowing older animals to be exposed to blood–and all the molecules and cells it carries– from young animals. They found that the procedure made the blood-forming stem cells in older animals act young again; the overall number of these cells decreased, and the cells generated different varieties of blood cells in more appropriate ratios. “In aged animals, many of the changes we see normally that are associated with age were reversed,” said Wagers.
But the retraction, signed by Wagers and two co-authors but not the lead author, says that reexamination of the data led to questions about the role of certain cells in the rejuvenation of in blood-forming stem cells in old mice. The Boston Globe reported that Wagers is now working with colleagues to replicate the experiments.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.